2021
DOI: 10.1080/10715762.2021.1964494
|View full text |Cite
|
Sign up to set email alerts
|

Vitamins E and C do not effectively inhibit low density lipoprotein oxidation by ferritin at lysosomal pH

Abstract: Low density lipoprotein (LDL) might be oxidized by iron in the lysosomes of macrophages in atherosclerotic lesions. We have shown previously that the iron-storage proteinferritin can oxidize LDL at lysosomal pH. We have now investigated the roles of the most important antioxidant contained in LDL, a-tocopherol (the main form of vitamin E) and of ascorbate (vitamin C), a major water-soluble antioxidant, on LDL oxidation by ferritin at lysosomal pH (pH 4.5). We incubated LDL with ferritin at pH 4.5 and 37 C and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 77 publications
1
1
0
Order By: Relevance
“…Although vit C inhibited LDL oxidation by myeloperoxidase in vitro, the dosage was too high to use practical applications, such as 50, 100, 150, and 200 mM [44]. In addition, vit C and E could not inhibit LDL oxidation by ferritin at lysosomal pH, which might help to explain why vit C and E did not reduce CVD in large clinical trials [45], which is in good agreement with the current results (Supplementary Figures S2 and S3). Several phenolic compounds and flavonoids have been developed as inhibitors of LDL oxidation [46].…”
Section: Discussionsupporting
confidence: 87%
“…Although vit C inhibited LDL oxidation by myeloperoxidase in vitro, the dosage was too high to use practical applications, such as 50, 100, 150, and 200 mM [44]. In addition, vit C and E could not inhibit LDL oxidation by ferritin at lysosomal pH, which might help to explain why vit C and E did not reduce CVD in large clinical trials [45], which is in good agreement with the current results (Supplementary Figures S2 and S3). Several phenolic compounds and flavonoids have been developed as inhibitors of LDL oxidation [46].…”
Section: Discussionsupporting
confidence: 87%
“…Although vit C inhibited LDL oxidation by myeloperoxidase in vitro, the dosage was too high to use practical application, such as 50, 100, 150, and 200 mM [42]. In addition, vit C and E could not inhibit LDL oxidation by ferritin at lysosomal pH, which might help to explain why vit C and E did not reduce CVD in large clinical trials [43]. Several phenolic compounds and flavonoids were developed as inhibitors of LDL oxidation [44]; new pharmaceutical agents are needed to maximize the antioxidant, anti-glycation, protection of HDL, and stabilization of apoA-I via an interaction of amphipathic helix domain.…”
Section: Discussionmentioning
confidence: 99%